GB0905954D0 - Treatment of exacerbations of asthma - Google Patents
Treatment of exacerbations of asthmaInfo
- Publication number
- GB0905954D0 GB0905954D0 GBGB0905954.4A GB0905954A GB0905954D0 GB 0905954 D0 GB0905954 D0 GB 0905954D0 GB 0905954 A GB0905954 A GB 0905954A GB 0905954 D0 GB0905954 D0 GB 0905954D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- exacerbations
- asthma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0905954.4A GB0905954D0 (en) | 2009-04-06 | 2009-04-06 | Treatment of exacerbations of asthma |
PCT/GB2010/000676 WO2010116127A1 (en) | 2009-04-06 | 2010-04-01 | Combination of cetirizine and mefenamic acid for the treatment of exacerbations of asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0905954.4A GB0905954D0 (en) | 2009-04-06 | 2009-04-06 | Treatment of exacerbations of asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0905954D0 true GB0905954D0 (en) | 2009-05-20 |
Family
ID=40750190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0905954.4A Ceased GB0905954D0 (en) | 2009-04-06 | 2009-04-06 | Treatment of exacerbations of asthma |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0905954D0 (en) |
WO (1) | WO2010116127A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8744398A (en) * | 1997-09-19 | 1999-04-12 | Procter & Gamble Company, The | Compositions and methods for treating respiratory disorders |
US6384038B1 (en) * | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
WO2001054685A1 (en) * | 2000-01-31 | 2001-08-02 | Genaera Corporation | Mucin synthesis inhibitors |
GB0719518D0 (en) * | 2007-10-05 | 2007-11-14 | Therapeutics Ltd E | Therapy |
-
2009
- 2009-04-06 GB GBGB0905954.4A patent/GB0905954D0/en not_active Ceased
-
2010
- 2010-04-01 WO PCT/GB2010/000676 patent/WO2010116127A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010116127A1 (en) | 2010-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL217901A0 (en) | Treatment of bdnf-related disorders using laquninimod | |
HK1217763A1 (en) | Methods of treating diseases | |
IL218575A0 (en) | Treatment of cancer | |
IL217824A0 (en) | Treatment of of macrophage-related disorders | |
ZA201304280B (en) | Treatment of jak2-mediated conditions | |
GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
IL214664A0 (en) | Methods of treating hair related conditions | |
HK1166472A1 (en) | Treatment of dyskinesia related disorders | |
IL206491A0 (en) | Treatment of produce | |
IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
IL256026A (en) | Methods of treatment | |
IL225896A0 (en) | Treatment of mecp2-associated disorders | |
GB0901456D0 (en) | Treatment of psoriasis | |
ZA201202213B (en) | Treatment of minerals | |
GB201018622D0 (en) | Treatment of liquids | |
GB0908101D0 (en) | Treatment of stress | |
IL200753A0 (en) | Treatment of psoriasis | |
ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
HK1178057A1 (en) | Treatment of osteoporosis | |
GB0901487D0 (en) | Asthma Therapy | |
GB0905954D0 (en) | Treatment of exacerbations of asthma | |
EP2440238A4 (en) | Methods of treatment | |
GB0904073D0 (en) | Treatment of influenza | |
GB0902157D0 (en) | Treatment of obesity | |
GB0921757D0 (en) | Treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |